BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
2.380
0.00 (0.00%)
Apr 15, 2026, 4:00 PM EDT - Market closed

BioLineRx Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1111171143697
Market Cap Growth
-7.89%-33.41%-84.97%213.28%-62.68%65.80%
Enterprise Value
5.361.097.5778.65-4.4241.85
Last Close Price
2.382.778.5662.8023.6081.60
PE Ratio
---1.43-1.74-1.31-3.40
PS Ratio
9.549.650.5923.69--
PB Ratio
0.480.631.278.600.711.43
P/TBV Ratio
0.540.631.277.630.601.32
P/FCF Ratio
--1.41-0.39-5.00-1.38-4.11
P/OCF Ratio
--1.41-0.39-5.03-1.38-4.13
EV/Sales Ratio
4.540.920.2616.39--
EV/EBITDA Ratio
--0.11-0.46-1.630.16-1.74
EV/EBIT Ratio
--0.11-0.37-1.580.15-1.69
EV/FCF Ratio
--0.13-0.17-3.460.17-1.77
Debt / Equity Ratio
0.230.230.750.600.200.03
Debt / EBITDA Ratio
-1.04-1.04-0.92-0.24-0.43-0.19
Debt / FCF Ratio
-1.25-1.25-0.34-0.51-0.47-0.20
Net Debt / Equity Ratio
-0.59-0.59-0.34-2.37-0.76-0.77
Net Debt / EBITDA Ratio
1.101.100.280.651.362.18
Net Debt / FCF Ratio
1.321.320.101.381.472.22
Asset Turnover
0.030.030.560.0700
Inventory Turnover
0.090.093.633.78--
Quick Ratio
1.761.761.531.034.855.89
Current Ratio
1.951.951.761.104.875.91
Return on Equity (ROE)
-11.01%-11.01%-69.11%-189.23%-41.96%-60.04%
Return on Assets (ROA)
-25.78%-25.78%-39.69%-70.84%-36.96%-38.51%
Return on Invested Capital (ROIC)
-80.93%-80.93%-235.40%-426.54%-171.24%-142.37%
Return on Capital Employed (ROCE)
-39.35%-39.35%-91.43%-114.44%-42.45%-45.75%
Earnings Yield
-10.44%0.00%-70.09%-57.32%-76.27%-29.41%
FCF Yield
-71.93%-71.16%-256.98%-19.98%-72.64%-24.34%
Buyback Yield / Dilution
-105.76%-105.76%-24.37%-24.47%-16.75%-162.19%
Total Shareholder Return
-105.76%-105.76%-24.37%-24.47%-16.75%-162.19%
Updated Mar 23, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q